A significant breakthrough in cancer study is occurring with the use of VHH fragments to re-engage damaged p53. This vital malignant inhibitor protein is frequently inactivated in several types of tumors, resulting https://bookmarks-hit.com/story336256/nanobodies-reactivate-tumor-suppressor-p53-the-potential-approach-for-tumor-management